The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Fecal transplantation for treatment of inflammatory bowel disease
Open accessAbstract
versus control for participants with ulcerative colitis, Outcome 17 Endoscopic response at 8 weeks..
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712 · cited 7×
“One of the proposed mechanisms for the development of IBD involves the interplay between microbes and the immune system, which may then lead to an abnormal inflammatory response in genetically susceptible individuals (Abraham 2009; Cleynen 2016).”
BackgroundInfluentialIntention-to-treat concept: A review
Gupta, S. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.83221 · Cited by 1,921
Epidemiology and risk factors for IBD
Ananthakrishnan, A. N. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.34 · Cited by 1,741
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276 · cited 73×
“Cochrane Database of Systematic Reviews Included studies Four randomized controlled trials assessed fecal microbiota transplantation for induction of remission in UC (Costello 2017a; Moayyedi 2015; Paramsothy 2017a; Rossen 2015).”
BackgroundMethodResultInfluentialEuropean consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.045 · Cited by 921
Research works printed but not linked: 66
- Costello, 2017, Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild moderately active ulcerative colitis: a randomised controlled trial, Journal of Crohn's and Colitis, 11, S23, 10.1093/ecco-jcc/jjx002.035 · DOI
- Moayyedi, 2014, A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis, Gastroenterology, 146, S, 10.1016/S0016-5085(14)60567-9 · DOI
- Paramsothy, 2016, Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: A randomised placebo-controlled trial, Gastroenterology, 150, S122, 10.1016/S0016-5085(16)30517-0 · DOI
- Paramsothy S Kamm MA Walsh AJ Bogaerde J Samuel D Leong RWL Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo controlled trial and microbiota analysis Journal of Gastroenterology and Hepatology 2016 143 · DOI
- Fuentes, 2017, Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation, ISME Journal, 11, 1877, 10.1038/ismej.2017.44 · DOI · Paper page
- Allegretti, 2016, Irregular bowel movements following fecal microbiota transplantation (FMT) are associated with pre-existing irritable bowel syndrome but not FMT-related factors, Gastroenterology, 150, S742, 10.1016/S0016-5085(16)32519-7 · doi:10.1016/s0016-5085(16)32519-7
- Borody, 2003, Treatment of ulcerative colitis using fecal bacteriotherapy, Journal of Clinical Gastroenterology, 37, 42, 10.1097/00004836-200307000-00012 · DOI · Paper page
- Chin, 2017, Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: A Single-Center Experience, Clinical Gastroenterology & Hepatology, 15, 597, 10.1016/j.cgh.2016.11.028 · DOI
- Fischer, 2016, Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 22, 2402, 10.1097/MIB.0000000000000908 · DOI · Paper page
- Gionchetti, 2000, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterology, 119, 305, 10.1053/gast.2000.9370 · DOI · Paper page
- Hourigan, 2015, Microbiome changes associated with sustained eradication of clostridium difficile after fecal microbiota transplantation in children with and without inflammatory bowel disease, Gastroenterology, S45, 10.1016/S0016-5085(15)30157-8 · DOI
- Ishikawa, 2017, Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis, Inflammatory Bowel Diseases, 23, 116, 10.1097/MIB.0000000000000975 · DOI
- Mandalia, 2016, Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile, International Journal of Colorectal Disease, 31, 1059, 10.1007/s00384-015-2396-2 · DOI
- Mintz, 2016, Comparing fecal microbial transplant outcomes in patients with recurrent clostridium difficile or ulcerative colitis, Inflammatory Bowel Diseases, 22, S31, 10.1097/01.MIB.0000480184.07677.0e · doi:10.1097/01.mib.0000480184.07677.0e
- Wei, 2016, Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora, BMC Microbiology, 16, 255, 10.1186/s12866-016-0869-2 · DOI
- NCT01961492, Fecal Microbiota Transplantation in Patients with Ulcerative Colitis, clinicaltrials.gov/ct2/show/NCT01961492
- Pai, 2017, Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial, BMJ Open, 7, 1, 10.1136/bmjopen-2017-016698 · DOI
- Pai, 2016, A randomized, placebo-controlled trial of fecal microbial transplantation for pediatric ulcerative colitis (pedifetch trial), Journal of Pediatric Gastroenterology and Nutrition, 63, S79
- NCT03104036, Faecal Bacteriotherapy for Ulcerative Colitis (FACTU), clinicaltrials.gov/ct2/show/NCT03104036
- Abraham, 2012, Natural history of pediatric-onset inflammatory bowel disease: a systematic review, Journal of Clinical Gastroenterology, 46, 581, 10.1097/MCG.0b013e318247c32f · DOI · Paper page
- Ahuja, 2010, Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences, Journal of Digestive Diseases, 11, 134, 10.1111/j.1751-2980.2010.00429.x · DOI · Paper page
- Alang, 2015, Weight gain after fecal microbiota transplantation, Open Forum Infectious Diseases, 2, ofv004, 10.1093/ofid/ofv004 · DOI · Paper page
- Armuzzi, 2012, Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease, Journal of Crohn's & Colitis, 6, 492, 10.1016/j.crohns.2011.12.016 · DOI
- Assa, 2016, Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease, Inflammatory Bowel Diseases, 22, 1533, 10.1097/MIB.0000000000000776 · DOI
- Austin, 2014, Fecal microbiota transplantation in the treatment of Clostridium difficile infections, American Journal of Medicine, 127, 479, 10.1016/j.amjmed.2014.02.017 · DOI
- Auzoux, 2016, Assessment of Mucosal Healing in Inflammatory Bowel Disease, Journal of Clinical Gastroenterology and Hepatology, 1, 1
- Bejaoui, 2015, Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons, Digestive Diseases, 33, 105, 10.1159/000437104 · DOI
- Cammarota, 2015, Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, Alimentary Pharmacology & Therapeutics, 41, 835, 10.1111/apt.13144 · DOI · Paper page
- Carding, 2017, Review article: the human intestinal virome in health and disease, Alimentary Pharmacology & Therapeutics, 46, 800, 10.1111/apt.14280 · DOI · Paper page
- Cleynen I Boucher G Jostins L Schumm LP Zeissig S Ahmad T Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study Lancet 2016 156 67 · DOI · Paper page
- Colman, 2014, Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis, Journal of Crohn's & Colitis, 8, 1569, 10.1016/j.crohns.2014.08.006 · DOI · Paper page
- Costello, 2017, Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis, Alimentary Pharmacology & Therapeutics, 46, 213, 10.1111/apt.14173 · DOI · Paper page
- Dahlhamer, 2016, Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥ 18 Years - United States, 2015, MMWR. Morbidity and Mortality Weekly Report, 65, 1166, 10.15585/mmwr.mm6542a3 · DOI · Paper page
- Dave, 2012, Mucosal healing in inflammatory bowel disease-a true paradigm of success?, Gastroenterology and Hepatology, 8, 29
- Preter, 2012, Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis, Inflammatory Bowel Diseases, 18, 2371, 10.1002/ibd.22949 · DOI · Paper page
- Dulai, 2015, Assessment of mucosal healing in inflammatory bowel disease: review, Gastrointestinal Endoscopy, 82, 246, 10.1016/j.gie.2015.03.1974 · DOI
- Feakins, 2013, Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines, Journal of Clinical Pathology, 66, 1005, 10.1136/jclinpath-2013-201885 · DOI · Paper page
- Fuentes, 2017, Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation, ISME Journal, 11, 1877, 10.1038/ismej.2017.44 · DOI · Paper page
- Hozo, 2005, Estimating the mean and variance from the median, range, and the size of a sample, BMC Medical Research Methodology, 20, 13, 10.1186/1471-2288-5-13 · DOI · Paper page
- Kelly, 2014, Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients, American Journal of Gastroenterology, 109, 1065, 10.1038/ajg.2014.133 · DOI · Paper page
- Kelly CR Khoruts A Staley C Sadowsky MJ Abd M Alani M Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial Annals of Internal Medicine 2016 609 16 · DOI · Paper page
- Khoruts, 2016, Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection, Clinical Gastroenterology & Hepatology, 14, 1433, 10.1016/j.cgh.2016.02.018 · DOI · Paper page
- Kostic, 2014, The microbiome in inflammatory bowel disease: current status and the future ahead, Gastroenterology, 146, 1489, 10.1053/j.gastro.2014.02.009 · DOI · Paper page
- Leffler, 2015, Clostridium difficile infection, New England Journal of Medicine, 372, 1539, 10.1056/NEJMra1403772 · DOI · Paper page
- Link, 2016, Endoscopic peroral jejunal fecal microbiota transplantation, Digestive & Liver Disease, 48, 1336, 10.1016/j.dld.2016.08.110 · DOI
- Mallon, 2007, Probiotics for induction of remission in ulcerative colitis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005573.pub2 · DOI · Paper page
- Mehta, 2016, Report: economic implications of inflammatory bowel disease and its management, American Journal of Managed Care, 22, s51
- Molodecky, 2012, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 46, 10.1053/j.gastro.2011.10.001 · DOI · Paper page
- Morgan, 2012, Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment, Genome Biology, 13, R79, 10.1186/gb-2012-13-9-r79 · DOI · Paper page
- Mowat C Cole A Windsor A Ahmad T Arnott I Driscoll R Guidelines for the management of inflammatory bowel disease in adults Gut 2011 571 607 · DOI · Paper page
- Nagao-Kitamoto, 2016, Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice, Cellular and Molecular Gastroenterology and Hepatology, 2, 468, 10.1016/j.jcmgh.2016.02.003 · DOI · Paper page
- Naidoo, 2011, Probiotics for maintenance of remission in ulcerative colitis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007443.pub2 · DOI
- Osman, 2016, Donor Efficacy in Fecal Microbiota Transplantation for Recurrent Clostridium difficile: Evidence From a 1,999-Patient Cohort, Open Forum Infectious Diseases, 3, 841, 10.1093/ofid/ofw194.48 · DOI
- Owens, 2013, Fecal microbiota transplantation and donor standardization, Trends in Microbiology, 21, 443, 10.1016/j.tim.2013.07.003 · DOI
- Petersen, 2014, Defining dysbiosis and its influence on host immunity and disease, Cellular Microbiology, 16, 1024, 10.1111/cmi.12308 · DOI · Paper page
- Peyrin-Biroulet, 2011 Oct, Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease, Journal of Crohn's & Colitis, 5, 477, 10.1016/j.crohns.2011.06.009 · DOI · Paper page
- Rapozo, 2017, Diet and microbiota in inflammatory bowel disease: The gut in disharmony, World Journal of Gastroenterology, 23, 2124, 10.3748/wjg.v23.i12.2124 · DOI · Paper page
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
- Schulberg, 2016, Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease, Internal Medicine Journal, 46, 266, 10.1111/imj.13003 · DOI
- Shi, 2016, Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis, PLoS One, 11, e0157259, 10.1371/journal.pone.0157259 · DOI
- Singh, 2015, Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001176.pub3 · DOI · Paper page
- Solari, 2014, Tempered enthusiasm for fecal transplant, Clinical Infectious Diseases, 59, 319, 10.1093/cid/ciu278 · DOI
- Sun, 2016, Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis, Medicine, 95, e3765, 10.1097/MD.0000000000003765 · DOI
- Vindigni, 2016, The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions, Therapeutic Advances in Gastroenterology, 9, 606, 10.1177/1756283X16644242 · DOI · Paper page
- Weintraub, 2014, Temporal trends in inflammatory bowel disease publications over a 19-years period, World Journal of Gastroenterology, 20, 16745, 10.3748/wjg.v20.i44.16745 · doi:10.3748/wjg.v20.i44.16745
- Witherden, 2017, The Human Mucosal Mycobiome and Fungal Community Interactions, Journal of Fungi, 3, 56, 10.3390/jof3040056 · DOI
Cited by
Antibiotics as Major Disruptors of Gut Microbiota
Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V. L., & Cohen, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572912 · Cited by 898
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
van Rheenen, P. F., Aloi, M., Assa, A., Bronsky, J., Escher, J. C., Fagerberg, U. L., Gasparetto, M., Gerasimidis, K., Griffiths, A., Henderson, P., et al. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa161 · Cited by 729
The Immunomodulatory Functions of Butyrate
Siddiqui, M. T., & Cresci, G. A. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s300989 · Cited by 381
MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis
Yao, D., Dai, W., Dong, M., Dai, C., & Wu, S. (2021) · eBioMedicine · doi:10.1016/j.ebiom.2021.103751 · Cited by 291
Ulcerative Colitis—Diagnostic and Therapeutic Algorithms
Kucharzik, T., Koletzko, S., Kannengießer, K., & Dignaß, A. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0564 · Cited by 268
Metadata
- Authors
- Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-11-13
- Volume
- 2018
- Issue
- 11
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4255727347
- Cited by
- 164
- References
- 21
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Update notices
- new_version (2023-04-25)
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fecal transplantation for treatment of inflammatory bowel disease. https://app.cochat.ai/papers/10.1002/14651858.cd012774.pub2
- The paper
- Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S. (2018). Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd012774.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.